IMPORTANT STATEMENT FROM THE ACR: "The American College of Rheumatology acknowledges President Trump's directive to the Food and Drug Administration asking them to 'fast track' potential treatments for COVID-19, including the antimalarials chloroquine and hydroxychloroquine.
Rheumatologists have extensive experience using these drugs and understand their safety and efficacy, including for our patients with rheumatic disease who take these medications on a regular basis. We hope that pragmatic clinical trials of these drugs can be done quickly...
to determine how well they work, who should get them, and at what point in the illness. If the demand for these drugs increases rapidly, we urge pharmaceutical companies to continue to provide these medications to mitigate drug shortages."
#COVID19
@ACRheum
There is no more hydroxychloroquine in my area of western Massachusetts. It literally happened suddenly today. My doctor called in an order for a 90 day supply on Monday. Yet the order at the pharmacy only allowed for a 30 day supply. No one can explain that to me. 1/1